Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg .............

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg
GLIMITERIS TRIO 0.2  
Voglibose is an alpha-glucosidase inhibitor.
It works by delaying the absorption of carbohydrates in the intestine. This results in slower and more gradual increases in blood sugar levels after meals.
It is commonly used in the management of type 2 diabetes.
Glimepiride is a sulfonylurea antidiabetic medication.
It works by stimulating the pancreas to release more insulin, which helps lower blood sugar levels.
It is primarily used for type 2 diabetes when diet and exercise alone are not sufficient to control blood sugar levels.
Metformin is a biguanide antidiabetic drug.
It helps reduce the amount of sugar produced by the liver and increases the sensitivity of the body's cells to insulin, allowing for better glucose utilization.
Metformin is often a first-line treatment for type 2 diabetes.
GLIMITERIS TRIO is available in strengths of 0.2gm and 0.3mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/glimiteris-trio-0-2-134376